Related Experiment Video
Updated: Jun 23, 2026
Deferred Growth Inhibition Assay to Quantify the Effect of Bacteria-derived Antimicrobials on Competition
Published on: September 3, 2016
Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects
Abstract:
Staphylococcus aureus in the nose is a risk factor for endogenous staphylococcal infection. UK guidelines recommend the use of mupirocin for nasal decolonization in certain groups of patients colonized with methicillin-resistant S. aureus (MRSA). Mupirocin is effective at removing S. aureus from the nose over a few weeks, but relapses are common within several months. There are only a few prospective randomized clinical trials that have been completed with sufficient patients, but those that have been reported suggest that clearance of S. aureus from the nose is beneficial in some patient groups for the reduction in the incidence of nosocomial infections. There is no convincing evidence that mupirocin treatment reduces the incidence of surgical site infection. New antibiotics are needed to decolonize the nose because bacterial resistance to mupirocin is rising, and so it will become less effective. Furthermore, a more bactericidal antibiotic than mupirocin is needed, on the grounds that it might reduce the relapse rate, and so clear the patient of MRSA for a longer period of time than mupirocin.
Insights
Nasal decolonization with mupirocin can reduce some infections but relapses are common. New, more effective antibiotics are needed to combat rising resistance and improve long-term clearance of Staphylococcus aureus.
Area of Science:
- Infectious Diseases
- Microbiology
- Clinical Pharmacology
Background:
- Nasal carriage of Staphylococcus aureus is a significant risk factor for endogenous infections.
- Current UK guidelines advocate mupirocin for nasal decolonization of methicillin-resistant S. aureus (MRSA).
- Mupirocin offers short-term S. aureus clearance, but frequent relapses occur within months.
Purpose of the Study:
- To evaluate the efficacy of nasal decolonization in reducing specific infection incidences.
- To assess the long-term effectiveness of mupirocin and identify limitations.
- To highlight the need for novel antibiotics against S. aureus nasal carriage.
Main Methods:
- Review of prospective randomized clinical trials on nasal decolonization.
- Analysis of data regarding S. aureus clearance rates and infection incidence.
- Assessment of bacterial resistance patterns to mupirocin.
Main Results:
- Limited high-quality trials suggest nasal S. aureus clearance benefits certain patient groups by reducing nosocomial infections.
- No conclusive evidence supports mupirocin's efficacy in preventing surgical site infections.
- Rising bacterial resistance to mupirocin is diminishing its effectiveness.
Conclusions:
- While mupirocin provides temporary S. aureus nasal clearance, its long-term efficacy is limited by relapses and increasing resistance.
- A more bactericidal antibiotic is required for sustained MRSA decolonization.
- Development of new antibiotics is crucial to overcome mupirocin resistance and improve patient outcomes.
More Related Videos
Related Concept Videos
01:25Clinical Significance of Antibiotic Resistance
01:29Staphylococcal Skin Infections
01:25Mechanism of Antibiotic Resistance in MRSA
01:28Antimicrobial Effectiveness
01:18Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
01:31Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...